Lynparza 150 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F1AS6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,274
Award facts
- Contract value 100% obligated
- $12,274.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,274.09 to AmerisourceBergen Drug Corp for the supply of Lynparza (olaparib) 150 mg tablets in a quantity of 120 units. The award, issued on January 28, 2026, is scheduled for completion by February 19, 2026, and utilizes firm fixed-price pricing with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where the awardee maintains its corporate headquarters. This delivery order is a child contract executed under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor within the federal medical supply chain, particularly supporting military and veteran healthcare systems. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to deliver a comprehensive range of pharmaceutical products across multiple therapeutic domains. Lynparza, an oncology medication, reflects the company's role in supplying specialty pharmaceuticals essential for military treatment facilities and defense health operations. The competitively awarded nature of this delivery order, combined with the company's established performance under the larger DLA Troop Support Medical indefinite delivery contract, underscores AmerisourceBergen's position as a qualified vendor for federal pharmaceutical procurement.
Quick answers
Who was awarded contract SPE2DR26F1AS6?
SPE2DR26F1AS6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F1AS6 worth?
The government has obligated $12,274 on SPE2DR26F1AS6.
Is contract SPE2DR26F1AS6 an order under another contract?
Yes. SPE2DR26F1AS6 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AS6 competed?
The extent of competition for SPE2DR26F1AS6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award